Clinical Trials on CDA Type I in Australia
Total 2970 results
-
Medical University of GrazCompletedDiabetes, Type IAustria
-
Glycomine, Inc.Recruiting24-Week Study to Assess the PD, Safety, Tolerability, and PK of GLM101 in Participants With PMM2-CDGPmm2-CDGSpain, Australia, United States
-
Medical University of ViennaCompletedType I DiabetesAustria
-
Capillary Biomedical, Inc.TerminatedType 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Type I | Diabetes Mellitus, Insulin-Dependent, 1 | IDDMAustria
-
University of Colorado, DenverNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes... and other collaboratorsRecruitingCDKL5 | CDKL5 Deficiency Disorder | CDDUnited States, Australia
-
University of MelbourneThe AlfredRecruitingHIV I InfectionSingapore, Australia
-
Arrowhead PharmaceuticalsCompletedHypertriglyceridemia | Familial ChylomicronemiaAustralia, Canada, New Zealand
-
Allergy TherapeuticsCompletedType I HypersensitivityUnited States, Canada, United Kingdom, Austria
-
Alexion PharmaceuticalsAchillion, a wholly owned subsidiary of AlexionCompletedC3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit Disease | Immune Complex Mediated Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis Types I, II, and IIINetherlands, Australia, Belgium
-
Medical University of GrazMedical University of ViennaUnknownPrevalent OPG and RANKL Excession in Patients With CADAustria
-
Landeskrankenhaus FeldkirchCompletedDiabetic Peripheral Neuropathy | Diabetes Mellitus Type I | Nerve Conduction Study Not PerformedAustria
-
Medical University InnsbruckParacelsus Medical University; Austrian Science Fund (FWF)CompletedSchizophrenia | Bipolar I DisorderAustria
-
University of AdelaideSalk Institute for Biological Studies; University of South AustraliaCompletedObesity | Type2 DiabetesAustralia
-
GlaxoSmithKlineCompletedNeisseria Meningitidis | Haemophilus Influenzae Type bAustralia
-
University of California, San FranciscoJuvenile Diabetes Research FoundationCompletedType 1 Diabetes Mellitus | Diabetes Mellitus, Type I | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | IDDMUnited States, Australia
-
Novartis PharmaceuticalsTerminatedSporadic Superficial and Nodular Skin Basal Cell CarcinomasAustria, Australia
-
The George InstituteNational Health and Medical Research Council, AustraliaCompletedIntracranial Hemorrhages | Cerebral Hemorrhage | CVA (Cerebrovascular Accident)Australia, New Zealand, China
-
Pharvaris Netherlands B.V.Active, not recruitingHereditary Angioedema | Hereditary Angioedema Type I | Hereditary Angioedema Type II | Hereditary Angioedema Types I and II | Hereditary Angioedema Attack | Hereditary Angioedema With C1 Esterase Inhibitor Deficiency | Hereditary Angioedema - Type 1 | Hereditary Angioedema - Type 2 | C1 Esterase Inhibitor... and other conditionsUnited States, Poland, Germany, Austria, Bulgaria, Canada, Ireland, Italy, United Kingdom
-
SunovionCompletedBipolar I DisorderUnited States, Croatia, Hungary, Poland, Serbia, Argentina, Japan, France, Slovakia, Australia, Russian Federation, Bulgaria, Chile, Czech Republic
-
Bristol-Myers SquibbActive, not recruiting
-
Regina Steringer-MascherbauerUnknownPulmonary Arterial Hypertension WHO Group IAustria
-
Telix International Pty LtdRecruitingGlioblastoma | Glioblastoma Multiforme | Neoplastic DiseaseAustralia, Austria, Netherlands, New Zealand
-
Bayside HealthCompletedNon-Hodgkin's Lymphoma | Hodgkin's DiseaseAustralia
-
Dren BioNovotechRecruitingAggressive NK Cell Leukemia | Hepatosplenic T-cell Lymphoma | Enteropathy-Associated T-Cell Lymphoma | Subcutaneous Panniculitis-Like T-Cell Lymphoma | Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma | LGLL - Large Granular Lymphocytic Leukemia | Primary Cutaneous T-Cell Lymphoma - Category and other conditionsUnited States, Australia, France, Spain
-
VASCage GmbHMedical University InnsbruckCompleted
-
KalVista Pharmaceuticals, Ltd.CompletedHereditary AngioedemaUnited States, Austria, Czechia, Germany, Hungary, Italy, Netherlands, North Macedonia, Poland, United Kingdom
-
Queensland Centre for Gynaecological CancerGlaxoSmithKline Research & Development LimitedNot yet recruitingMmr Deficiency | Endometrial Cancer Stage I | Immune-related Adverse Event | Endometrioid Endometrial AdenocarcinomaAustralia
-
Royal Perth HospitalRecruitingObesity | Type 2 Diabetes Mellitus | Metabolic SyndromeAustralia
-
AstraZenecaCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1Australia
-
German Breast GroupPfizer; AGO Study Group; Breast International Group; NSABP Foundation IncCompletedBreast Cancer | Hormonreceptor Positive | Her2-normal | Postneoadjuvant Treatment With CDK 4/6 Inhibitor | CPS-EG ScoreUnited States, Australia, Austria, Canada, France, Germany, Ireland, Japan, Korea, Republic of, Spain, United Kingdom
-
National Cancer Institute (NCI)Active, not recruitingPRETEXT I Hepatoblastoma | PRETEXT II Hepatoblastoma | PRETEXT III Hepatoblastoma | PRETEXT IV HepatoblastomaUnited States, Canada, Puerto Rico, Australia, Japan, Brazil
-
University of AdelaideRecruitingType 2 Diabetes | Shift-work DisorderAustralia
-
University of AdelaideRoyal Adelaide HospitalCompletedInsulin Resistance | Diabetes Mellitus, Type IIAustralia
-
Melanoma and Skin Cancer Trials LimitedRecruitingNeuroendocrine Tumors | Merkel Cell Carcinoma | Merkel Cell Carcinoma, Stage I | Merkel Cell Carcinoma, Stage II | Merkel Cell Carcinoma, Stage III | Carcinoma Neuroendocrine SkinAustralia, New Zealand
-
Trans Tasman Radiation Oncology GroupAustralasian Leukaemia and Lymphoma GroupCompletedPrimary Central Nervous System LymphomaAustralia, New Zealand
-
Telix International Pty LtdCompletedGlioblastoma MultiformeAustria, Australia, Netherlands
-
South Metropolitan Health ServiceTelix Pharmaceuticals (Innovations) Pty LimitedCompletedUrothelial CarcinomaAustralia
-
Carmot Therapeutics, Inc.Carmot Australia First Pty LtdRecruiting
-
Novartis PharmaceuticalsTerminatedPhilidelphia Positive Chronic Myeloid LeukaemiaAustralia
-
Children's Oncology GroupNational Cancer Institute (NCI)Completed
-
The Netherlands Cancer InstituteBristol-Myers SquibbActive, not recruitingMalignant Melanoma Stage IIIAustria, Netherlands, Australia, Sweden
-
Capillary Biomedical, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Insulin-Dependent, 1Australia
-
University of AdelaideCompletedInsulin Resistance | Type 2 DiabetesAustralia
-
GlaxoSmithKlineCompletedHib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate VaccinesNeisseria Meningitidis | Haemophilus Influenzae Type bAustralia
-
HighTide Biopharma Pty LtdCompleted
-
Lipotek Pty LtdRoyal Adelaide Hospital; Trident Clinical Research Pty LtdCompleted
-
IpsenActive, not recruitingNeuroendocrine TumorsAustria, Denmark, Switzerland, Australia, United Kingdom, France
-
Monash UniversityUniversity of Victoria; University of Auckland, New ZealandCompleted
-
University of AdelaideCompletedObesity | Type 2 DiabetesAustralia
-
LipimetiX Development, LLCCompletedHypercholesterolemia | Hyperlipoproteinemia Type IIAustralia